Healthcare -
Biotechnology - NASDAQ - US
$ 2.237
1.68 %
$ 59.3 M
Market Cap
-2.09
P/E
Price Target
Average
--100.00%
Revenue Forecast
Estimate
1120.38%
EBIT
Estimate
--65.18%
Net Income
Estimate
14.49%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Gain Therapeutics, Inc.
GANX has no price targets from Wall Street.
REVENUE FORECAST
Revenue Forecast Chart GANX
EBIT FORECAST
EBIT Forecast Chart GANX
NET INCOME FORECAST
Net Income Chart GANX